Published on in Vol 27 (2025)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/62836, first published .
Mortality Risk Prediction in Patients With Antimelanoma Differentiation–Associated, Gene 5 Antibody–Positive, Dermatomyositis–Associated Interstitial Lung Disease: Algorithm Development and Validation

Mortality Risk Prediction in Patients With Antimelanoma Differentiation–Associated, Gene 5 Antibody–Positive, Dermatomyositis–Associated Interstitial Lung Disease: Algorithm Development and Validation

Mortality Risk Prediction in Patients With Antimelanoma Differentiation–Associated, Gene 5 Antibody–Positive, Dermatomyositis–Associated Interstitial Lung Disease: Algorithm Development and Validation

Hui Li   1, 2 * , MD ;   Ruyi Zou   1 * , MD ;   Hongxia Xin   3 * , MD ;   Ping He   4 * , MD ;   Bin Xi   5 * , MD ;   Yaqiong Tian   1 , MD ;   Qi Zhao   1 , MD, PhD ;   Xin Yan   1 , MD ;   Xiaohua Qiu   1 , MD ;   Yujuan Gao   1 , MD, PhD ;   Yin Liu   1 , MD ;   Min Cao   1 , MD ;   Bi Chen   5 , MD, PhD ;   Qian Han   6 , MD, PhD ;   Juan Chen   3 , MD, PhD ;   Guochun Wang   7 , MD, PhD ;   Hourong Cai   1 , MD

1 Department of Respiratory and Critical Care Medicine, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, China

2 Department of Pulmonary and Critical Care Medicine, Seventh Affiliated Hospital, Sun Yatsen University, Shenzhen, China

3 Department of Pulmonary and Critical Care Medicine, General Hospital of Ningxia Medical University, Yinchuan, China

4 Department of Respiratory and Critical Care Medicine, Third People’s Hospital of Chengdu, Chengdu, China

5 Department of Respiratory and Critical Care Medicine, Affiliated Hospital of Xuzhou Medical University, Xuzhou, China

6 National Center for Respiratory Medicine, First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China

7 China-Japan Friendship Hospital, Key Laboratory of Myositis (Beijing Key Laboratory for Immune Mediated Inflammatory Diseases), Department of Rheumatology, Beijing, China

*these authors contributed equally

Corresponding Author:

  • Hourong Cai, MD
  • Department of Respiratory and Critical Care Medicine
  • Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School
  • Nanjing University
  • 321 Zhongshan Rd., Gulou District
  • Nanjing, 210008
  • China
  • Phone: 86 025-83106666
  • Email: caihourong2013@163.com